STOCK TITAN

DILLARD'S (DDS) SEC Filings, Oct 1-29, 2025

DDS OTC
Rhea-AI Summary

Dillard's, Inc. (DDS) reported an insider transaction by Senior Vice President and Director William T. Dillard III. On 10/27/2025, he acquired 14 shares of Common Class A at $623.52 per share.

Following the transaction, reported beneficial ownership included: 31,720 shares direct; 15,763 shares direct (Common Class A); 189,065 shares indirect as trustee for a family trust; and 13,655 shares indirect owned by spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Dillard's, Inc. (DDS) director and Executive Vice President Mike Dillard reported acquiring 23 Class A shares at $623.52 on 10/27/2025 under a Form 4.

Following the transaction, he beneficially owns 536,988 Class A shares directly, plus indirect holdings of 41,496 shares through W.D. Company, Inc. and 7,300 shares as trustee of the GST Trust. Footnotes state he owns 26.3% of W.D. Company, Inc., which also holds 3,985,776 shares of Class B Common Stock, convertible into Class A on a one‑for‑one basis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Dillard’s (DDS) President and director Alex Dillard reported an insider purchase. On 10/27/2025, he acquired 14 shares of Class A common stock at $623.52 per share. Following the transaction, he beneficially owns 1,018,867 Class A shares directly.

He also reports indirect holdings of 41,496 shares through W.D. Company, Inc., 7,300 shares as trustee of a GST trust, and 36,560 shares owned by his spouse. The filing notes he disclaims beneficial ownership of indirectly held shares except to the extent of his pecuniary interest. W.D. Company, Inc. holds 3,985,776 Class B shares convertible into Class A on a one-for-one basis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Dillard's (DDS) reported an insider stock purchase by a vice president. On 10/27/2025, the officer acquired 10 shares of Common Class A at $623.52 per share (Transaction Code A).

Following the transaction, the officer beneficially owned 1,281 shares directly. A separate line item shows Common Class A held in a Retirement Plan totaling 7,186 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Dillard's (DDS) director J C Watts Jr. reported an open-market sale of 750 shares of Common Class A on 10/16/2025 at $594.60 per share. After this transaction, he beneficially owns 10,250 shares held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Dillard’s (DDS): Notice of proposed insider sale. A holder filed a Form 144 to sell up to 750 shares of Dillard’s common stock. The filing lists an aggregate market value of $442,024.80 and an approximate sale date of October 16, 2025. The shares are slated to be sold on the NYSE through Raymond James & Associates.

The shares to be sold were acquired via stock awards from the issuer on three dates: 400 shares on May 20, 2024, 100 shares on May 19, 2023, and 250 shares on May 22, 2017, with cash noted as the form of payment at acquisition.

The signer represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Summary

Dean L. Worley, VP/General Counsel & Secretary of Dillard's, Inc. (DDS) reported a purchase on 09/29/2025 of 10 shares of Common Class A at a price of $622.50 per share. After the transaction the filing shows Mr. Worley directly beneficially owns 6,402 Common Class A shares and indirectly owns 3,483 shares through a retirement plan. The Form 4 is signed and dated 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Phillip R. Watts, identified as a Senior Vice President and officer of Dillard's, Inc. (DDS), reported an open-market acquisition on 09/29/2025 in a Form 4 filing. The filing shows 11 shares of Common Class A were acquired with a transaction code "A" and a reported price of $622.5. After the reported transaction, Mr. Watts is recorded as beneficially owning 8,905 shares directly and 10,317 shares in a retirement plan. The Form 4 is signed by Mr. Watts on 10/01/2025. The disclosure is a routine insider transaction showing a small purchase by a named officer and does not include derivative activity or other transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Insider purchase reported: James D. Stockman, Vice President and director-level officer of Dillard's, Inc. (DDS), reported acquiring 13 shares of Class A common stock on 09/29/2025 at a price shown as $622.5 per share. After the transaction he beneficially owned 35,267 shares directly, plus 21,093 shares held in a retirement plan. The Form 4 is signed by the reporting person on 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Brant Musgrave, Corporate VP Stores at Dillard's (DDS), reported an acquisition on 09/29/2025. He purchased 9 shares of Dillard's Class A common stock at a reported price of $622.50 per share, increasing his direct holdings to 3,631 shares. The filing also shows 8,461 Class A shares held indirectly in a retirement plan. The Form 4 is signed on 10/01/2025 and discloses no derivative transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many DILLARD'S (DDS) SEC filings are available on StockTitan?

StockTitan tracks 286 SEC filings for DILLARD'S (DDS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for DILLARD'S (DDS)?

The most recent SEC filing for DILLARD'S (DDS) was filed on October 29, 2025.